Trastuzumab and Cardiotoxicity

QR Code

Trastuzumab and Cardiotoxicity

None

Saved in:

Bibliographic Details
Main Authors:	Fiuza, M., Magalhães, A.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/32613
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Trastuzumab-Resistance and Breast Cancer
by: Dokmanovic, Milos, et al.
Published: (2011)

Anthracycline Cardiotoxicity
by: Visani, Giuseppe, et al.
Published: (2012)

Early Detection and Prediction of Cardiotoxicity - Biomarker and Echocardiographic Evaluation
by: Kinova, Elena, et al.
Published: (2012)

Neuregulin1-ErbB Signaling in Doxorubicin-Induced Cardiotoxicity
by: Goukassian, David, et al.
Published: (2012)

Cardiotoxicity of Anticancer Drugs
by: I. Maiborodin, et al.
Published: (2025-02-01)

Mechanisms of the Cardiotoxic Action of Amitriptyline
by: G. V. Chekmarev, et al.
Published: (2011-12-01)

Nuclear imaging of chemotherapy-induced cardiotoxicity
by: A. A. Ansheles, et al.
Published: (2021-03-01)

CHEMOTHERAPY CARDIOTOXICITY SCREENING WITH CARDIAC TROPONINS
by: O. V. Krikunova, et al.
Published: (2015-12-01)

Genetic basis of anthracyclines cardiotoxicity: Literature review
by: M. Yu. Sinitsky, et al.
Published: (2021-10-01)

RADIATION-INDUCED TOXICITY IN BREAST CANCER PATIENTS TREATED WITH TRASTUZUMAB-BASED CHEMOTHERAPY
by: R. Yu. Karabut, et al.
Published: (2021-08-01)

CARDIOTOXICITY ANTIPSYCHOTICS: MORPHO-ELECTROCARDIOGRAPHIC ASSOCIATIONS
by: V. P. Volkov
Published: (2015-12-01)

Development and Validation of the ELISA Method for Anti-trastuzumab Antibodies Determination in Human Serum
by: O. A. Eliseeva, et al.
Published: (2022-12-01)

Cardiotoxic Drugs Used in the Treatment of COVID-19
by: A. S. Zmitrukevich, et al.
Published: (2024-01-01)

POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: V. I. Chernov, et al.
Published: (2016-02-01)

Detection of anti-drug antibodies to trastuzumab in serum by enzyme-linked immunosorbent assay
by: V. V. Pisarev, et al.
Published: (2025-06-01)

STUDY CARDIOTOXIC PROPERTIES OF NATIVE PEAT HUMIC ACIDS
by: M. V. Belousov, et al.
Published: (2014-02-01)

Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future
by: A. M. Chaulin, et al.
Published: (2022-03-01)

The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
by: D. A. Andreev, et al.
Published: (2024-09-01)

Cardiotoxic Effects of Yew Tree and Pink Periwinkle Alkaloids
by: G. S. Mal, et al.
Published: (2021-12-01)

Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update
by: Vasvi Bhutani, et al.
Published: (2025-05-01)

Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
by: Rongrong Bai, et al.
Published: (2025-06-01)

Capecitabine, Tucatinib, and Trastuzumab Chemotherapy-associated Diabetic Ketoacidosis: A Case Report
by: Wei-Shin Lu, et al.
Published: (2025-06-01)

In Vitro Evaluation of the Efficient Passage of PLGA-Formulated Trastuzumab for Nose-to-Brain Delivery
by: Léa Kengne Kamkui, et al.
Published: (2025-05-01)

Validation of ELISA Test-system for Trastuzumab (Herceptin, Hertikad) quantitative determination in biological fluids
by: V. V. Pisarev, et al.
Published: (2023-05-01)

Synthetic antioxidant TS-13 reduces doxorubicin cardiotoxicity
by: E. B. Menshchikova, et al.
Published: (2023-10-01)

MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)

CARDIOTOXICITY AND METHODS OF ITS DIAGNOSIS IN HEMATOLOGY PATIENTS (REVIEW)
by: T. P. Kuzmina, et al.
Published: (2019-03-01)

Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity?
by: A. M. Chaulin, et al.
Published: (2023-05-01)

Development and Validation of the ELISA Method for Neutralizing Anti-trastuzumab Antibodies Detection in Human Blood Serum
by: M. A. Kolganova, et al.
Published: (2023-05-01)

Dermatomyositis induced by trastuzumab in post-operative treatment of breast cancer: A case report
by: Ruidan Zhao, et al.
Published: (2025-08-01)

The Efficacy of Trastuzumab in Animal Models of Breast Cancer: A Systematic Review and Meta-Analysis.
by: Jiarong Chen, et al.
Published: (2016-01-01)

Exceptional response to trastuzumab deruxtecan in recurrent neuroendocrine cervical cancer: A case report
by: Lauren Tostrud, et al.
Published: (2025-08-01)

Utility of myocardial work by echocardiography in the early diagnosis of cardiotoxicity
by: Denise Cortes-Pérez, et al.
Published: (2025-04-01)

Non-Coding RNAs in the Regulation of Doxorubicin-Induced Cardiotoxicity
by: Mengyao Sun, et al.
Published: (2025-05-01)

Modeling the impact of using trastuzumab deruxtecan in patients with breast cancer on reducing cancer mortality in Russia
by: N. A. Avxentyev, et al.
Published: (2024-07-01)

Modifying effect of iron citrate to cardiotoxicity of lead acetate in an experiment
by: Nefedova E.A.
Published: (2014-12-01)

Cardiovascular complications in patients with cancer: focus on anthracycline-induced cardiotoxicity
by: I. T. Murkamilov, et al.
Published: (2021-03-01)

Potential of primary drug prevention of cardiotoxicity in the context of anticancer therapy
by: Yu. A. Vasyuk, et al.
Published: (2023-01-01)

Curcumin exerts protective effects against doxorubicin-induced cardiotoxicity
by: O. О. Klymenko, et al.
Published: (2025-02-01)

Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial
by: Mark Hensley, et al.
Published: (2025-07-01)